Hind Lal

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Circulation research

Cardiovascular drugs and therapy

Basic research in cardiology

Journal of the American Heart Association

UAB Hospital

Indian Institute of Toxicology Research CSIR (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UAB Hospital May 01 2019

United States

Associate Professor :: Cardiology

Vanderbilt University May 15 2014 - Apr 30 2019

United States

Assistant Professor of Medicine :: Cardiovascular Medicine

Temple University Jan 01 2012 - May 15 2014

United States

Associate Scientist :: Center for Translational Medicine

Education History

Indian Institute of Toxicology Research CSIR Apr 01 2001 - Sep 13 2005

India

PHD :: Petroleum Toxicology

Dr Ram Manohar Lohia Avadh University Jun 01 1997 - Jun 01 1999

India

MSC :: Microbiology

Publications

Hind Lal, Suresh Kumar Verma, Yajing Wang, Min Xie, Martin E Young
Circadian Rhythms in Cardiovascular Metabolism. Circulation research 134 (6) (2024)
Hind Lal, Suresh Kumar Verma, Yajing Wang, Min Xie, Martin E Young
Circadian Rhythms in Cardiovascular Metabolism. Circulation research 134 (6) (2024)
Hind Lal, Suresh Kumar Verma, Yajing Wang, Min Xie, Martin E Young
Circadian Rhythms in Cardiovascular Metabolism. Circulation research 134 (6) (2024)
Hind Lal, Suresh Kumar Verma, Yajing Wang, Min Xie, Martin E Young
Circadian Rhythms in Cardiovascular Metabolism. Circulation research 134 (6) (2024)
Hind Lal, Suresh Kumar Verma, Yajing Wang, Min Xie, Martin E Young
Circadian Rhythms in Cardiovascular Metabolism. Circulation research 134 (6) (2024)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Chae-Myeong Ha, Sayan Bakshi, Manoja K Brahma, Luke A Potter, Samuel F Chang, Zhihuan Sun, Gloria A Benavides, Lihao He, Prachi Umbarkar, Luyun Zou, Samuel Curfman, Sini Sunny, Andrew J Paterson, Namakkal-Soorappan Rajasekaran, Jarrod W Barnes, Jianhua Zhang, Hind Lal, Min Xie, Victor M Darley-Usmar, John C Chatham, Adam R Wende
Sustained Increases in Cardiomyocyte Protein O -Linked β-N-Acetylglucosamine Levels Lead to Cardiac Hypertrophy and Reduced Mitochondrial Function Without Systolic Contractile Impairment. Journal of the American Heart Association (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Prachi Umbarkar, Suma Ejantkar, Sulivette Y Ruiz Ramirez, Angelica Toro Cora, Qinkun Zhang, Sultan Tousif, Hind Lal
Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis. Basic research in cardiology 118 (1) (2023)
Prachi Umbarkar, Sultan Tousif, Anand Prakash Singh, Joshua C Anderson, Qinkun Zhang, Michelle D Tallquist, James Woodgett, Hind Lal
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Circulation research 131 (7) (2022)
Mallikarjun Patil, Sherin Saheera, Praveen K Dubey, Asher M Kahn-Krell, Prem Kumar Govindappa, Sarojini Singh, Sultan Tousif, Qinkun Zhang, Hind Lal, Jianyi Jay Zhang, Gangjian Qin, Prasanna Krishnamurthy
Novel Mechanisms of Exosome-Mediated Phagocytosis of Dead Cells in Injured Heart. Circulation research 129 (11) (2021)
Manisha Gupte, Prachi Umbarkar, Anand Prakash Singh, Qinkun Zhang, Sultan Tousif, Hind Lal
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity. Cells 9 (5) (2020)
Manisha Gupte, Prachi Umbarkar, Hind Lal
Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al. Cardiovascular drugs and therapy 31 (3) (2018)

Hind Lal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hind Lal